FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula Ia or IIa, where R1, R3 and R4 have the values specified in the patent claim. Invention also relates to a composition for treating inflammatory or autoimmune state and use of compounds of formulae Ia or IIa in preparing a medicine for treating an inflammatory disorder or an autoimmune disorder.
EFFECT: compounds, which are the subject of the invention, are effective for treating states associated with interleukin-1 receptor-associated kinase (IRAK), particularly IRAK-1 and/or IRAK-4.
9 cl, 1 tbl, 52 of preparatory ex, 31 ex
Title | Year | Author | Number |
---|---|---|---|
AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
NITROGEN-CONTAINING HETEROARYL DERIVATIVES | 2011 |
|
RU2559895C2 |
PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
4-PHENOXY-NICOTANIMIDES OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDES | 2011 |
|
RU2565077C2 |
Authors
Dates
2016-12-10—Published
2011-07-08—Filed